Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ensysce Biosciences Inc (NQ: ENSC ) 0.2343 +0.0062 (+2.72%) Streaming Delayed Price Updated: 3:55 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ensysce Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Ensysce Biosciences to Present Clinical Dataset at Major PAINWeek Scientific Symposium August 14, 2023 Via ACCESSWIRE Ensysce Biosciences Reports Second Quarter 2023 Financial Results August 11, 2023 Via ACCESSWIRE Ensysce Biosciences Announces IRB Approval of Key Study Protocol August 08, 2023 Via ACCESSWIRE Ensysce Biosciences Announces Engagement of Alacrita Consulting July 26, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Intraday Session July 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 04, 2023 Via Benzinga Ensysce Biosciences to Participate in Upcoming Industry Events June 06, 2023 Via ACCESSWIRE Ensysce Biosciences Reports First Quarter 2023 Financial Results May 15, 2023 Via ACCESSWIRE Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today? May 09, 2023 With Ensysce Biosciences achieving testing success regarding its overdose protection drug, ENSC stock soared on the implications. Via InvestorPlace Why Ensysce Biosciences Stock Surged Today July 03, 2023 Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares popped Monday following positive coverage from HC Wainwright. The firm put a price target on the stock far above current levels. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 03, 2023 Via Benzinga Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 03, 2023 Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Via Benzinga Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection May 09, 2023 Via ACCESSWIRE Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development April 19, 2023 Via ACCESSWIRE Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website April 11, 2023 Via ACCESSWIRE Nasdaq Edges Lower; ISM Manufacturing PMI Drops In June July 03, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.16% to 34,462.62 while the NASDAQ fell 0.03% to 13,784.02. The S&P 500, also... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023 July 03, 2023 Via Benzinga Ensysce Biosciences and Quotient Sciences to Present MPAR(R) Overdose Protection Platform at Upcoming CRS 2023 Annual Meeting and Expo June 27, 2023 Via ACCESSWIRE Ensysce Biosciences Regains Compliance with Nasdaq June 13, 2023 Via ACCESSWIRE Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website June 07, 2023 Via ACCESSWIRE Stocks That Hit 52-Week Lows On Friday May 19, 2023 On Friday, 63 companies hit new 52-week lows. Via Benzinga Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering May 12, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 10, 2023 Via Benzinga Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering May 10, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Intraday Session May 09, 2023 Via Benzinga Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study May 09, 2023 Ensysce Biosciences, Inc. (NASDAQ: ENSC) operates as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology to Via Spotlight Growth Exposures Product Safety Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 09, 2023 Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. Via Benzinga Why Are Ensysce Biosciences Shares Are Trading Higher Today May 09, 2023 Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the company's first pain medication with overdose protection, Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 09, 2023 Via Benzinga Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 19, 2023 Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.